Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 10 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 38 most recent Form 4 transactions.
| Sep 4 | PCVX | Vaxcyte, Inc. | SSELL◷? | 1,381 | $61.16 | $84.5K | -0.9% | Open the original filing on SEC.gov |
| Sep 2 | PCVX | Vaxcyte, Inc. | FTAX | 1,432 | $61.58 | $88.2K | -0.9% | Open the original filing on SEC.gov |
| Sep 1 | PCVX | Vaxcyte, Inc. | MEXER◆ | 2,250 | — | — | — | Open the original filing on SEC.gov |
| Sep 1 | PCVX | Vaxcyte, Inc. | SSELL◷? | 303 | $61.42 | $18.6K | -0.2% | Open the original filing on SEC.gov |
| Sep 1 | PCVX | Vaxcyte, Inc. | SSELL◷? | 924 | $60.96 | $56.3K | -0.6% | Open the original filing on SEC.gov |
| Sep 1 | PCVX | Vaxcyte, Inc. | SSELL◷? | 713 | $61.48 | $43.8K | -0.4% | Open the original filing on SEC.gov |
| Sep 1 | PCVX | Vaxcyte, Inc. | SSELL◷? | 1,537 | $60.89 | $93.6K | -1.0% | Open the original filing on SEC.gov |
| Sep 1 | PCVX | Vaxcyte, Inc. | MEXER | 2,250 | $5.35 | $12K | +1.4% | Open the original filing on SEC.gov |
| Aug 31 | PCVX | Vaxcyte, Inc. | FTAX | 1,273 | $60.74 | $77.3K | -0.8% | Open the original filing on SEC.gov |
| Aug 3 | PCVX | Vaxcyte, Inc. | MEXER◷◆ | 2,250 | — | — | — | Open the original filing on SEC.gov |
| Aug 3 | PCVX | Vaxcyte, Inc. | SSELL◷ | 1,389 | $54.09 | $75.1K | -0.9% | Open the original filing on SEC.gov |
| Aug 3 | PCVX | Vaxcyte, Inc. | SSELL◷ | 861 | $53.50 | $46.1K | -0.5% | Open the original filing on SEC.gov |
| Aug 3 | PCVX | Vaxcyte, Inc. | MEXER◷ | 2,250 | $5.35 | $12K | +1.4% | Open the original filing on SEC.gov |
| Jul 1 | PCVX | Vaxcyte, Inc. | MEXER◷◆ | 516 | — | — | — | Open the original filing on SEC.gov |
| Jul 1 | PCVX | Vaxcyte, Inc. | SSELL◷ | 6 | $57.82 | $347 | 0.0% | Open the original filing on SEC.gov |
| Jul 1 | PCVX | Vaxcyte, Inc. | SSELL◷ | 456 | $57.47 | $26.2K | -0.3% | Open the original filing on SEC.gov |
| Jul 1 | PCVX | Vaxcyte, Inc. | SSELL◷ | 1,788 | $56.03 | $100.2K | -1.1% | Open the original filing on SEC.gov |
| Jul 1 | PCVX | Vaxcyte, Inc. | MEXER◷ | 516 | $5.35 | $2.8K | +0.3% | Open the original filing on SEC.gov |
| Jun 1 | PCVX | Vaxcyte, Inc. | SSELL◷ | 301 | $50.26 | $15.1K | -0.2% | Open the original filing on SEC.gov |
| Jun 1 | PCVX | Vaxcyte, Inc. | SSELL◷ | 1,949 | $49.40 | $96.3K | -1.2% | Open the original filing on SEC.gov |
| May 1 | PCVX | Vaxcyte, Inc. | SSELL◷ | 2,250 | $56.83 | $127.9K | -1.4% | Open the original filing on SEC.gov |
| Apr 1 | PCVX | Vaxcyte, Inc. | SSELL◷ | 838 | $58.93 | $49.4K | -0.5% | Open the original filing on SEC.gov |
| Apr 1 | PCVX | Vaxcyte, Inc. | SSELL◷ | 1,412 | $58.14 | $82.1K | -0.9% | Open the original filing on SEC.gov |
| Mar 10 | PCVX | Vaxcyte, Inc. | SSELL◷ | 4,968 | $59.16 | $293.9K | -2.9% | Open the original filing on SEC.gov |
| Mar 10 | PCVX | Vaxcyte, Inc. | SSELL◷ | 2,427 | $58.32 | $141.5K | -1.4% | Open the original filing on SEC.gov |
| Mar 9 | PCVX | Vaxcyte, Inc. | FTAX◷ | 975 | $59.32 | $57.8K | -0.6% | Open the original filing on SEC.gov |
| Mar 2 | PCVX | Vaxcyte, Inc. | FTAX | 1,009 | $61.98 | $62.5K | -0.6% | Open the original filing on SEC.gov |
| Feb 28 | PCVX | Vaxcyte, Inc. | FTAX | 898 | $61.98 | $55.7K | -0.5% | Open the original filing on SEC.gov |
| Feb 27 | PCVX | Vaxcyte, Inc. | FTAX | 1,900 | $61.74 | $117.3K | -1.1% | Open the original filing on SEC.gov |
| Feb 27 | PCVX | Vaxcyte, Inc. | AGRANT | 5,102 | $61.74 | $315K | +2.9% | Open the original filing on SEC.gov |
| Feb 26 | PCVX | Vaxcyte, Inc. | AGRANT◆ | 53,566 | — | — | — | Open the original filing on SEC.gov |
| Feb 26 | PCVX | Vaxcyte, Inc. | AGRANT | 32,045 | — | — | +22.6% | Open the original filing on SEC.gov |
| Sep 8, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 2,759 | $32.41 | $89.4K | -1.9% | Open the original filing on SEC.gov |
| Sep 2, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 1,429 | $31.56 | $45.1K | -1.0% | Open the original filing on SEC.gov |
| Sep 2, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 1,587 | $31.56 | $50.1K | -1.1% | Open the original filing on SEC.gov |
| Sep 2, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 1,270 | $31.56 | $40.1K | -0.8% | Open the original filing on SEC.gov |